Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with ...

Favorable early safety and initial efficacy data from BEST1 program highlighted at premier gathering of global retinal ...

Many people think eye exams are only useful for checking vision. However, scientists have discovered that our eyes can reveal much more about our health than just how well we see. In particular, the ...

Experts believe the retina may predict Alzheimer's risk because it is part of the central nervous system and connected ...

What if the darkness that enveloped a child's world suddenly… vanished? What if hope, once a whisper, roared into life with a ...

People typically die from progressive supranuclear palsy within 7 to 10 years. There is currently no specialized treatment or effective screening for this neurodegenerative disease.

Wall Street's attention has turned to biotech firm Ocugen as it advances its gene therapy programs for inherited retinal diseases. While clinical development pr ...

Schulman, Ph.D. We have known for some time that changes in the eye may help detect Alzheimer’s disease — a type of dementia affecting about 32 million people globally. Previous research has linked ...

The one-day event will be held Saturday, April 18, 2026, at the Indianapolis Marriott Downtown in Indianapolis, IN, and is ...

Researchers develop a 96% accurate AI-powered retinal scan to distinguish between Alzheimer’s and ALS by detecting specific protein deposits.

This year’s Rare Disease Day event Feb. 27 at the Jacobs School of Medicine and Biomedical Sciences focused on updates in research and diagnostics, and advancements in treatment.

The retina is a thin layer of neural tissue at the back of the eye that detects light and converts it into signals, sent to the brain.